SLC23A4P

Across TCGA pan-cancer cohorts, SLC23A4P RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of SLC23A4P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where SLC23A4P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SLC23A4P is over-expressed in tumor, although a few such as KICH and BRCA show the opposite, repressed pattern.

KIRC, HNSC, and KICH are the cancer types where SLC23A4P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SLC23A4P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	II,III,IV	+2.009	<.001	12	view →
HNSC	All	III,IV	+0.320	<.001	10	view →
KICH	All	All	−0.215	.001	7	view →
KIRP	Male	All	+0.928	<.001	6	view →
LUSC	All	All	+0.211	<.001	3	view →
PAAD	Male	All	+0.175	.019	2	view →
BRCA	All	III,IV	−0.046	.002	2	view →
THCA	All	All	−0.023	.011	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

SLC23A4P–KIRC

Open the KIRC breakdown →